Date: 09 Nov 2012
Endothelial progenitor cells: the promise of cell-based therapies for acute lung injury
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Endothelial progenitor cells (EPCs) are defined as a special type of stem cell that have been found to directly incorporate into injured vessels and that participate in angiogenesis and reconstruction by differentiation into endothelial cells. EPCs are widely used to therapeutically treat cardiovascular disease, limb ischemia and vascular repair. However, the role of EPCs in inflammatory diseases, especially in lung injury, is less studied.
To investigate the application of EPCs to vascular repair, and the role of EPCs in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
A computer-based online search was performed in the PubMed database and Web of Science database for articles published, concerning EPCs, angiogenesis, ALI/ARDS and stem cell transplantation
EPCs have a therapeutic potential for vascular regeneration and may emerge as novel strategy for the diseases that are associated with ALI/ARDS.
Responsible Editor: Artur Bauhofer.
Hung HS, Shyu WC, Tsai CH, Hsu SH, Lin SZ. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases. Cell Transpl. 2009;18:1003–12.CrossRef
Sheridan M, Donnelly M, Bailie R, Power M, Seigne P, et al. Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management. Crit Care. 2008;12:R30.
Matuschak GM, Lechner AJ. Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment. Mo Med. 2010;107:252–8.PubMed
Tomashefski JF Jr, Davies P, Boggis C, Greene R, Zapol WM, et al. The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol. 1983;112:112–26.PubMed
Naruse K, Nakamura J. Therapeutic vasculogenesis using endothelial progenitor cells for treatment of diabetic neuropathies. Nihon Rinsho. 2005;63(Suppl 6):622–6.PubMed
Ding DC, Shyu WC, Lin SZ, Li H. The role of endothelial progenitor cells in ischemic cerebral and heart diseases. Cell Transpl. 2007;16:273–84.
Tsuchiya K, Hida K, Hida Y, Muraki C, Ohga N, et al. Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization. Int J Oncol. 2010;36:1379–86.PubMed
Hennig B, Alvarado A. Nutrition and endothelial cell integrity: implications in atherosclerosis. Prog Food Nutr Sci. 1993;17:119–57.PubMed
Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol. 2004;172:1266–72.PubMed
Wary KK, Vogel SM, Garrean S, Zhao YD, Malik AB. Requirement of alpha(4)beta(1) and alpha(5)beta(1) integrin expression in bone-marrow-derived progenitor cells in preventing endotoxin-induced lung vascular injury and edema in mice. Stem Cells. 2009;27:3112–20.PubMed
- Endothelial progenitor cells: the promise of cell-based therapies for acute lung injury
Volume 62, Issue 1 , pp 3-8
- Cover Date
- Print ISSN
- Online ISSN
- SP Birkhäuser Verlag Basel
- Additional Links
- Endothelial progenitor cells
- Acute lung injury
- Acute respiratory distress syndrome
- Stem cell transplantation
- Industry Sectors